Back to KROS
Invesco Ltd. KROS Position History
Keros Therapeutics, Inc. • Healthcare
Quarters held
12
Latest value
$715K
Q3 2026
Peak value
$1.2M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $445K |
| Q4 2025 | $95K |
| Q4 2025 | $1.2M |
| Q1 2026 | $241K |
| Q1 2026 | $44K |
| Q1 2026 | $684K |
| Q2 2026 | $81K |
| Q2 2026 | $24K |
| Q2 2026 | $661K |
| Q3 2026 | $79K |
| Q3 2026 | $24K |
| Q3 2026 | $715K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $715K | 62.7K | — | — |
| Q3 2026 | $24K | 2.1K | — | — |
| Q3 2026 | $79K | 6.9K | — | — |
| Q2 2026 | $661K | 61.7K | — | — |
| Q2 2026 | $24K | 2.2K | — | — |
| Q2 2026 | $81K | 7.6K | — | — |
| Q1 2026 | $684K | 61.9K | — | — |
| Q1 2026 | $44K | 4.0K | — | — |
| Q1 2026 | $241K | 21.9K | — | — |
| Q4 2025 | $1.2M | 60.9K | — | — |
| Q4 2025 | $95K | 4.7K | — | — |
| Q4 2025 | $445K | 21.9K | — | — |